4.4 Article

MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway

Micaela Freitas et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2018)

Review Oncology

Determinants of metastatic competency in colorectal cancer

Daniele V. F. Tauriello et al.

MOLECULAR ONCOLOGY (2017)

Review Oncology

Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study

David Tougeron et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Review Biochemistry & Molecular Biology

Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored

Stephen K. H. Li et al.

TRENDS IN MOLECULAR MEDICINE (2016)

Review Oncology

Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study

David Tougeron et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Review Medicine, Research & Experimental

Colon cancer: Cancer stem cells markers, drug resistance and treatment

Zuzana Kozovska et al.

BIOMEDICINE & PHARMACOTHERAPY (2014)

Article Biotechnology & Applied Microbiology

Acidic tumor microenvironment downregulates hMLH1 but does not diminish 5-fluorouracil chemosensitivity

Moriya Iwaizumi et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2013)

Article Pathology

MLH1 function is context dependent in colorectal cancers

Thomas Jackson et al.

JOURNAL OF CLINICAL PATHOLOGY (2011)

Article Gastroenterology & Hepatology

Promoter hypermethylation and loss of CD133 gene expression in colorectal cancers

You-Kyung Jeon et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2010)

Article Oncology

Targeted modulation of MGMT: Clinical implications

LL Liu et al.

CLINICAL CANCER RESEARCH (2006)